FY2024 Earnings Forecast for Teladoc Health, Inc. (NYSE:TDOC) Issued By Cantor Fitzgerald

Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2024 earnings estimates for Teladoc Health in a research report issued to clients and investors on Monday, April 29th. Cantor Fitzgerald analyst S. James anticipates that the health services provider will post earnings of ($1.00) per share for the year. Cantor Fitzgerald currently has a "Overweight" rating and a $22.00 price target on the stock. The consensus estimate for Teladoc Health's current full-year earnings is ($1.06) per share.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The firm had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. During the same quarter last year, the firm earned ($0.37) EPS. The company's revenue was up 2.7% on a year-over-year basis.

TDOC has been the subject of several other research reports. Evercore ISI reduced their price objective on shares of Teladoc Health from $15.00 to $14.00 and set an "in-line" rating for the company in a research report on Friday, April 26th. Piper Sandler reduced their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an "overweight" rating for the company in a research report on Wednesday, February 21st. Stifel Nicolaus reduced their price objective on shares of Teladoc Health from $21.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, April 26th. DA Davidson reduced their price objective on shares of Teladoc Health from $22.00 to $18.00 and set a "neutral" rating for the company in a research report on Wednesday, February 21st. Finally, TD Cowen reduced their price objective on shares of Teladoc Health from $16.00 to $15.00 and set a "hold" rating for the company in a research report on Friday, April 26th. Twelve equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Teladoc Health presently has an average rating of "Hold" and an average price target of $18.73.

Teladoc Health Stock Up 0.4 %

NYSE TDOC traded up $0.05 on Wednesday, hitting $12.81. 4,405,258 shares of the stock were exchanged, compared to its average volume of 4,832,734. The company has a quick ratio of 3.47, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. Teladoc Health has a fifty-two week low of $12.53 and a fifty-two week high of $30.41. The company has a market cap of $2.17 billion, a PE ratio of -8.95 and a beta of 0.94. The company has a 50-day moving average price of $14.54 and a 200-day moving average price of $17.63.

Insider Transactions at Teladoc Health

In other news, insider Arnnon Geshuri sold 7,500 shares of the company's stock in a transaction on Monday, March 25th. The shares were sold at an average price of $15.06, for a total transaction of $112,950.00. Following the transaction, the insider now directly owns 38,470 shares of the company's stock, valued at approximately $579,358.20. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, insider Arnnon Geshuri sold 7,500 shares of the stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $15.06, for a total value of $112,950.00. Following the sale, the insider now directly owns 38,470 shares of the company's stock, valued at approximately $579,358.20. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Jason N. Gorevic sold 53,755 shares of the stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $780,522.60. Following the completion of the sale, the chief executive officer now directly owns 653,073 shares in the company, valued at $9,482,619.96. The disclosure for this sale can be found here. Insiders have sold a total of 135,441 shares of company stock valued at $2,038,251 in the last ninety days. 0.95% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

Large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its position in shares of Teladoc Health by 11.8% in the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider's stock worth $377,451,000 after acquiring an additional 1,855,480 shares during the last quarter. ARK Investment Management LLC lifted its position in Teladoc Health by 4.5% during the fourth quarter. ARK Investment Management LLC now owns 21,224,565 shares of the health services provider's stock valued at $457,389,000 after buying an additional 912,692 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in Teladoc Health by 25.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider's stock valued at $82,636,000 after buying an additional 767,999 shares in the last quarter. Norges Bank acquired a new position in Teladoc Health during the fourth quarter valued at approximately $9,714,000. Finally, Charles Schwab Investment Management Inc. lifted its position in Teladoc Health by 37.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,549,585 shares of the health services provider's stock valued at $28,807,000 after buying an additional 418,909 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.